StockMarketWire.com - Amryt Pharma said a consortium it is leading had been awarded grant funding of €8.4m over three years by the Irish government to develop a non-viral gene therapy platform.

The grant was part of the government's Disruptive Technologies Innovation Fund.

It was awarded a consortium comprised of Amryt, University College Dublin, Curran Scientific and Debra Ireland.

The funding would be matched by the consortium partners at various funding levels over the three-year term of the project, Amryt Pharma said.


At 1:08pm: [LON:AMYT] Amryt Pharma share price was +1p at 14.5p



Story provided by StockMarketWire.com